Tenaya Therapeutics Inc
NASDAQ:TNYA 3:59:51 PM EDT
Earnings Announcements
Tenaya Therapeutics Reports Fourth Quarter And Year-End 2021 Results
Published: 03/23/2022 20:51 GMT
Tenaya Therapeutics Inc (TNYA) - Tenaya Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Updates.
Tenaya Therapeutics Inc - Expects Current Cash, Equivalents, Etc Will Be Sufficient to Fund Current Operating Plan at Least Into H2 2023.
Tenaya Therapeutics Inc - Expects Current Cash, Equivalents, Etc Will Be Sufficient to Fund Current Operating Plan at Least Into H2 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.78
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.84
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.78
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.84
More details on our Analysts Page.